KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2016 - 2026)

Teva Pharmaceutical Industries (TEVA) has disclosed Asset Utilization Ratio for 18 consecutive years, with 0.43 as the latest value for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 9.21% to 0.43 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.43 through Mar 2026, up 9.21% year-over-year, with the annual reading at 0.43 for FY2025, 7.87% up from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 0.43 at Teva Pharmaceutical Industries, roughly flat from 0.43 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.43 in Q1 2026, with the low at 0.33 in Q1 2022.
  • Average Asset Utilization Ratio over 5 years is 0.37, with a median of 0.37 recorded in 2024.
  • The widest YoY moves for Asset Utilization Ratio: up 14.1% in 2025, down 4.32% in 2025.
  • Teva Pharmaceutical Industries' Asset Utilization Ratio stood at 0.34 in 2022, then increased by 9.5% to 0.37 in 2023, then rose by 1.33% to 0.38 in 2024, then rose by 14.1% to 0.43 in 2025, then rose by 0.3% to 0.43 in 2026.
  • Per Business Quant, the three most recent readings for TEVA's Asset Utilization Ratio are 0.43 (Q1 2026), 0.43 (Q4 2025), and 0.39 (Q3 2025).